UnitedHealth Group Just Signaled Its Turnaround Is Finally Here

Photo of Rich Duprey
By Rich Duprey Published

Quick Read

  • UnitedHealth (UNH) delivered a 9.38% EPS beat in Q1 2026 with medical cost ratio improving to 83.9%, the sharpest recovery after peaking at 89.9% in Q3 2025.

  • UnitedHealth’s managed care business is stabilizing after three quarters of margin deterioration, positioning full-year guidance of $18.25+ adjusted EPS as achievable.

  • It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for yourself (Sponsor)
    DISCLOSURE:
    INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
UnitedHealth Group Just Signaled Its Turnaround Is Finally Here

© Wolterk / iStock Editorial via Getty Images

UnitedHealth Group (NYSE:UNH | UNH Price Prediction) delivered its most convincing quarter in over a year on April 21, 2026, posting a 9.38% EPS beat and raising full-year guidance, sending shares up 6.96% on the day to close at $346.01. After three consecutive quarters of margin deterioration and a catastrophic Q4 2025 GAAP EPS collapse to $0.01, investors got the turnaround signal they had been waiting for: a medical cost ratio that snapped back sharply and guidance that moved higher.

Q1 2026 Earnings Scorecard

Category Grade Key Insight
Revenue Performance B+ $111.72B reported vs. $109.66B estimated, a 1.88% beat with 1.96% YoY growth; solid top-line expansion anchored by UnitedHealthcare Community & State revenue rising 4% YoY to $24.07B, driven by Medicaid rate updates.
Earnings Beat/Miss A Reported EPS of $7.23 vs. the $6.61 consensus estimate, a 9.38% beat; a sharp reversal from the 8.27% EPS miss in Q2 2025 and near-zero GAAP result in Q4 2025.
Forward Guidance A- Full-year 2026 adjusted EPS guidance raised to greater than $18.25, up from the prior $17.75 target set in Q4 2025; management committed to at least $2.0B in share buybacks through end of Q2 2026.
Profit Margins B+ Medical cost ratio improved 90 basis points to 83.9%, a dramatic recovery from the 89.9% MCR in Q3 2025; UnitedHealthcare operating margin expanded 40 basis points to 6.6%, though operating cost ratio widened to 13.8% from 12.4% due to AI and cybersecurity investment.
Cash Generation A Operating cash flow surged 63.34% YoY to $8.91B, equal to 1.4x net income; the company paid $2.01B in dividends in Q1 while holding $31.23B in cash and equivalents.
Management Tone B+ CEO Stephen Hemsley stated: “We are continuing to help simplify and modernize health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity.” Tone was measured and constructive, though DOJ legal actions and Medicare Advantage membership losses of 965,000 temper enthusiasm.

Bottom Line

Q1 2026 is the clearest evidence that UnitedHealth’s managed care business is stabilizing. The MCR improvement to 83.9% matters most: after peaking at 89.9% in Q3 2025, cost discipline and repricing across all business lines are working. Medicaid rate updates flow through Community & State revenues, and specialty pharmacy growth lifts Optum Rx to $35.74B in revenue. Analysts hold a consensus target of $363.19, with 22 buy or strong buy ratings vs. just 2 sell ratings. The key watch for Q2 2026 is whether Optum Health, which saw revenues fall 3% YoY to $24.11B from fewer value-based care members, reverses that decline as membership stabilizes. If the MCR holds near current levels and Optum recovers, the raised full-year guidance of greater than $18.25 in adjusted EPS looks achievable.

Photo of Rich Duprey
About the Author Rich Duprey →

After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, and Money Morning. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.

Continue Reading

Top Gaining Stocks

F Vol: 216,261,152
ENPH Vol: 11,512,758
ON Vol: 21,618,191
AKAM Vol: 10,964,520
HPE Vol: 27,523,481

Top Losing Stocks

CTRA Vol: 73,319,495
FDS Vol: 1,153,303
CEG Vol: 6,653,829
J Vol: 2,649,092
PODD Vol: 1,990,609